Clinical Stage Biopharma Co. Sienna Hits Ch. 11 In Del.
Sienna Biopharmaceuticals Inc., a research and development outfit that focuses on dermatology products, filed for bankruptcy Monday in Delaware to stave off a looming default on roughly $10 million in debt....To view the full article, register now.
Already a subscriber? Click here to view full article